Stroke Partnering 2007-2012

By Author: Bharat Book Bureau
Total Articles: 1486
Comment this article

Summary

The Stroke Partnering 2007-2012 report provides understanding and access to the stroke partnering deals and agreements entered into by the worlds leading healthcare companies. http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/stroke-partnering-2007-2012.html

Trends in stroke partnering deals
Top stroke deals by value
Deals listed by company A-Z, industry sector, stage of development, technology type
Description

The Stroke Partnering 2007-2012 provides understanding and access to the stroke partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides an analysis of stroke partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors stroke technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process ...
... in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.

This data driven report contains over 80 links to online copies of actual stroke deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

The initial chapters of this report provide an orientation of stroke partnering trends.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in stroke partnering since 2007, including a summary of deals by industry sector, stage of development, deal type, and technology type. Numerous tables provide outline financial trends.

Chapter 3 provides an overview of the leading stroke deals since 2007. Deals are listed by headline value, signed by bigpharma, most active bigpharma. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 4 provides a comprehensive directory of stroke partnering deals signed and announced since 2007. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the
research, development and commercialization of stroke technologies and products.

Report scope

Stroke Partnering 2007-2012 is intended to provide the reader with an in-depth understanding and access to stroke trends and structure of deals entered into by leading companies worldwide.

This data driven report includes:
Trends in stroke dealmaking in the biopharma industry since 2007
Access to summary headline, upfront, milestone and royalty data
The leading stroke deals by value since 2007
In Stroke Partnering 2007-2012, the available deals are listed by:

Headline value
Upfront payment value
Royalty rate value
Company A-Z
Industry sector
Stage of development at signing
Deal component type
Technology type
Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Benefits

Stroke Partnering 2007-2012 provides the reader with the following key benefits:
In-depth understanding of stroke deal trends since 2007
Access to summary headline, upfront, milestone and royalty data
Comprehensive access to over 80 actual stroke deals entered into by the world’s biopharma companies since 2007
Insight into key deal terms included in contracts, where disclosed
Understand the key deal terms companies have agreed in deals
Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in stroke partnering
2.1. Introduction
2.2. Stroke partnering over the years
2.3. Bigpharma stroke dealmaking activity
2.4. Stroke partnering by deal type
2.5. Stroke partnering industry sector
2.6. Stroke partnering by stage of development
2.7. Stroke partnering by technology type
2.8. Disclosed financial deal terms for stroke partnering
2.8.1 Stroke headline values
2.8.2 Stroke upfront payments
2.8.3 Stroke milestone payments
2.8.4 Stroke royalty rates

Chapter 3 – Leading stroke deals
3.1. Introduction
3.2. Top stroke deals by value
3.3. Top stroke deals involving bigpharma

For more information kindly visit :
Stroke Partnering 2007-2012

Or

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Fax: + 91 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: https://twitter.com/BharatBook
Our Blogs: http://in.linkedin.com/pub/bharat-book/3a/98/512
http://financemarketreports.blogspot.com/